L17 - Liver pathology Flashcards
What are the conditions that predispose individuals to primary liver tumors?
Chronic hepatitis B and C, cirrhosis, toxin exposure (aflatoxins), metabolic conditions like hemochromatosis, and genetic predispositions.
What is the most common malignancy found in the liver?
Metastatic tumors from other primary cancers.
Why is the liver a frequent site for metastasis?
The liver has a dual blood supply from the hepatic artery and portal vein, making it highly susceptible to metastases.
Which primary liver carcinoma is the most common?
Hepatocellular carcinoma (HCC).
What are common sources of metastatic liver tumors?
Gastrointestinal tract, breast, and lung cancers.
What chronic viral infections significantly increase the risk of hepatocellular carcinoma?
Hepatitis B and C.
How does cirrhosis contribute to liver cancer development?
Cirrhosis results in liver damage and regenerative nodules, increasing cancer risk.
What toxin exposure is associated with hepatocellular carcinoma?
Aflatoxins.
Which metabolic condition increases the risk of liver cancer?
Hemochromatosis.
What imaging studies are commonly used to diagnose liver tumors?
Ultrasound, CT scans, MRI.
Which serum biomarker is useful for detecting hepatocellular carcinoma?
Alpha-fetoprotein (AFP).
Why is AFP not always definitive for hepatocellular carcinoma?
AFP levels are not elevated in all cases, and other conditions can cause elevation.
When might a liver biopsy be necessary for diagnosis?
When imaging and serum markers are inconclusive.
What are the primary treatment options for liver tumors?
Surgical resection, liver transplantation, systemic therapies.
When is liver transplantation a viable treatment option?
For patients with cirrhosis and early-stage hepatocellular carcinoma.
What systemic treatments are emerging for liver tumors?
Targeted therapies and immunotherapy.
When is chemotherapy typically used for liver tumors?
For non-resectable or metastatic tumors.
What is transarterial chemoembolization (TACE)?
A minimally invasive procedure that delivers chemotherapy directly to liver tumors.
What histopathological features characterize hepatocellular carcinoma?
Trabecular or pseudoglandular growth patterns with vascular invasion, sometimes with Mallory-Denk bodies.
Which cytoplasmic inclusions may be present in hepatocellular carcinoma?
Mallory-Denk bodies.
What immunohistochemistry markers help distinguish hepatocellular carcinoma?
HepPar-1, glypican-3, arginase-1.
How do metastatic liver tumors differ histologically from primary liver tumors?
Metastatic tumors resemble their primary cancer site.
Which markers help identify colorectal cancer metastases in the liver?
CK20 and CDX2.
Which markers help identify breast cancer metastases in the liver?
ER/PR positivity.